Effects of Two Malaria Treatments in Nigerian Children
Author Information
Author(s): Michael Obaro S, Gbotosho Grace O, Folarin Onikepe A, Okuboyejo Titilope, Sowunmi Akintunde, Oduola Ayoade MJ, Happi Christian T
Primary Institution: University of Ibadan, Ibadan, Nigeria
Hypothesis
How do the early effects of artemether-lumefantrine and artesunate-amodiaquine on malaria parasites differ in Nigerian children?
Conclusion
Both artemether-lumefantrine and artesunate-amodiaquine are highly effective in treating malaria in Nigerian children, with similar efficacy and minimal side effects.
Supporting Evidence
- 42% of children receiving artemether-lumefantrine showed an initial rise in parasitaemia.
- Both treatments had cure rates above 90% at days 3, 7, 14, 28, and 42.
- Adverse events were mild and transient, with no serious complications reported.
Takeaway
This study looked at how two malaria treatments work in kids. Both treatments are good at getting rid of the malaria bugs quickly.
Methodology
The study was a randomized controlled trial comparing the effects of artemether-lumefantrine and artesunate-amodiaquine on malaria in children aged 12 to 132 months.
Potential Biases
Potential bias due to lack of blinding in treatment allocation.
Limitations
The study was not blinded, and the follow-up period may not capture long-term effects.
Participant Demographics
Children aged 12 to 132 months, with a mix of male and female participants.
Statistical Information
P-Value
0.377
Confidence Interval
95% CI: 5.95 - 7.38 for age
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website